Targeting pathophysiological changes using biomaterials-based drug delivery systems: A key to managing inflammatory bowel disease

Inflammatory bowel disease (IBD) is a gastrointestinal disorder, affecting about several million people worldwide. Current treatments fail to adequately control some clinical symptoms in IBD patients, which can adversely impact the patient’s quality of life. Hence, the development of new treatments...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohajeri, Sahar, Moayedi, Saeed, Mohajeri, Shabnam, Yadegar, Abbas, Haririan, Ismaeil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685402/
https://www.ncbi.nlm.nih.gov/pubmed/36438794
http://dx.doi.org/10.3389/fphar.2022.1045575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685402/
https://www.ncbi.nlm.nih.gov/pubmed/36438794
http://dx.doi.org/10.3389/fphar.2022.1045575

Ejemplares similares